Diagnostic ultrasound ( PDFDrive )

562 PART II Abdominal and Pelvic Sonography
153. Timmerman D, Verguts J, Konstantinovic ML, et al. he pedicle artery sign
based on sonography with color Doppler imaging can replace second-stage
tests in women with abnormal vaginal bleeding. Ultrasound Obstet Gynecol.
2003;22(2):166-171.
154. Baldwin MT, Dudiak KM, Gorman B, Marks CA. Focal intracavitary masses
recognized with the hyperechoic line sign at endovaginal US and characterized
with hysterosonography. Radiographics. 1999;19(4):927-935.
155. Karlsson B, Granberg S, Hellberg P, Wikland M. Comparative study of
transvaginal sonography and hysteroscopy for the detection of pathologic
endometrial lesions in women with postmenopausal bleeding. J Ultrasound
Med. 1994;13(10):757-762.
156. National Cancer Institute Surveillance, Epidemiology, and End Results
Program (SEER). SEER Stat Fact Sheets: Eendometrial cancer. 2015. Available
from: http://seer.cancer.gov/statfacts/html/corp.html.
157. Bourne TH, Campbell S, Steer CV, et al. Detection of endometrial cancer
by transvaginal ultrasonography with color low imaging and blood low
analysis: a preliminary report. Gynecol Oncol. 1991;40(3):253-259.
158. Weiner Z, Beck D, Rottem S, et al. Uterine artery low velocity waveforms
and color low imaging in women with perimenopausal and postmenopausal
bleeding. Correlation to endometrial histopathology. Acta Obstet Gynecol
Scand. 1993;72(3):162-166.
159. Chan FY, Chau MT, Pun TC, et al. Limitations of transvaginal sonography
and color Doppler imaging in the diferentiation of endometrial carcinoma
from benign lesions. J Ultrasound Med. 1994;13(8):623-628.
160. Carter JR, Lau M, Saltzman AK, et al. Gray scale and color low Doppler
characterization of uterine tumors. J Ultrasound Med. 1994;13(11):
835-840.
161. Sladkevicius P, Valentin L, Marsal K. Endometrial thickness and Doppler
velocimetry of the uterine arteries as discriminators of endometrial status
in women with postmenopausal bleeding: a comparative study. Am J Obstet
Gynecol. 1994;171(3):722-728.
162. Kurjak A, Shalan H, Sosic A, et al. Endometrial carcinoma in postmenopausal
women: evaluation by transvaginal color Doppler ultrasonography. Am J
Obstet Gynecol. 1993;169(6):1597-1603.
163. Sheth S, Hamper UM, McCollum ME, et al. Endometrial blood low
analysis in postmenopausal women: can it help diferentiate benign from
malignant causes of endometrial thickening? Radiology. 1995;195(3):
661-665.
164. Cacciatore B, Lehtovirta P, Wahlstrom T, Ylostalo P. Preoperative sonographic
evaluation of endometrial cancer. Am J Obstet Gynecol. 1989;160(1):
133-137.
165. Gordon AN, Fleischer AC, Reed GW. Depth of myometrial invasion in
endometrial cancer: preoperative assessment by transvaginal ultrasonography.
Gynecol Oncol. 1990;39(3):321-327.
166. Fleischer AC, Dudley BS, Entman SS, et al. Myometrial invasion by
endometrial carcinoma: sonographic assessment. Radiology. 1987;162(2):
307-310.
167. Mascilini F, Testa AC, Van Holsbeke C, et al. Evaluating myometrial and
cervical invasion in women with endometrial cancer: comparing subjective
assessment with objective measurement techniques. Ultrasound Obstet
Gynecol. 2013;42(3):353-358.
168. DelMaschio A, Vanzulli A, Sironi S, et al. Estimating the depth of myometrial
involvement by endometrial carcinoma: eicacy of transvaginal sonography
vs MR imaging. AJR Am J Roentgenol. 1993;160(3):533-538.
169. Yamashita Y, Mizutani H, Torashima M, et al. Assessment of myometrial
invasion by endometrial carcinoma: transvaginal sonography vs contrastenhanced
MR imaging. AJR Am J Roentgenol. 1993;161(3):595-599.
170. Kinkel K, Kaji Y, Yu KK, et al. Radiologic staging in patients with endometrial
cancer: a meta-analysis. Radiology. 1999;212(3):711-718.
171. Frei KA, Kinkel K, Bonel HM, et al. Prediction of deep myometrial invasion
in patients with endometrial cancer: clinical utility of contrast-enhanced
MR imaging—a meta-analysis and Bayesian analysis. Radiology.
2000;216(2):444-449.
172. Lalwani N, Dubinsky T, Javitt MC, et al. American College of Radiology
(ACR). Appropriateness Criteria: pretreatment evaluation and follow-up
of endometrial cancer. Ultrasound Q. 2014;30(1):21-28.
173. American Cancer Society. Endometrial (uterine) cancer. 2015. Available
from: http://www.cancer.org/cancer/endometrialcancer.
174. Sohaib SA, Verma H, Attygalle AD, Ind TE. Imaging of uterine malignancies.
Semin Ultrasound CT MR. 2010;31(5):377-387.
175. D’Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol.
2010;116(1):131-139.
176. Kim JA, Lee MS, Choi JS. Sonographic indings of uterine endometrial
stromal sarcoma. Korean J Radiol. 2006;7(4):281-286.
177. Fedele L, Bianchi S, Dorta M, Vignali M. Intrauterine adhesions: detection
with transvaginal US. Radiology. 1996;199(3):757-759.
178. Salle B, Gaucherand P, de Saint Hilaire P, Rudigoz RC. Transvaginal
sonohysterographic evaluation of intrauterine adhesions. J Clin Ultrasound.
1999;27(3):131-134.
179. Alhilli MM, Wall DJ, Brown DL, et al. Uterine ultrasound indings ater
radiofrequency endometrial ablation: correlation with symptoms. Ultrasound
Q. 2012;28(4):261-268.
180. Sharp HT. Endometrial ablation: postoperative complications. Am J Obstet
Gynecol. 2012;207(4):242-247.
181. McCausland AM, McCausland VM. Long-term complications of endometrial
ablation: cause, diagnosis, treatment, and prevention. J Minim Invasive
Gynecol. 2007;14(4):399-406.
182. Nowitzki KM, Hoimes ML, Chen B, et al. Ultrasonography of intrauterine
devices. Ultrasonography. 2015;34(3):183-194.
183. Moschos E, Twickler DM. Does the type of intrauterine device afect conspicuity
on 2D and 3D ultrasound? AJR Am J Roentgenol. 2011;196(6):
1439-1443.
184. Benacerraf BR, Shipp TD, Bromley B. hree-dimensional ultrasound detection
of abnormally located intrauterine contraceptive devices which are a source
of pelvic pain and abnormal bleeding. Ultrasound Obstet Gynecol. 2009;34(1):
110-115.
185. Braaten KP, Benson CB, Maurer R, Goldberg AB. Malpositioned intrauterine
contraceptive devices: risk factors, outcomes, and future pregnancies. Obstet
Gynecol. 2011;118(5):1014-1020.
186. Khati NJ, Parghi CR, Brindle KA. Multimodality imaging of the Essure
permanent birth control device: emphasis on commonly overlooked
abnormalities. AJR Am J Roentgenol. 2011;196(5):W648-W658.
187. Wittmer MH, Brown DL, Hartman RP, et al. Sonography, CT, and MRI
appearance of the Essure microinsert permanent birth control device. AJR
Am J Roentgenol. 2006;187(4):959-964.
188. Legendre G, Gervaise A, Levaillant JM, et al. Assessment of three-dimensional
ultrasound examination classiication to check the position of the tubal
sterilization microinsert. Fertil Steril. 2010;94(7):2732-2735.
189. Guelfguat M, Gruenberg TR, Dipoce J, Hochsztein JG. Imaging of mechanical
tubal occlusion devices and potential complications. Radiographics.
2012;32(6):1659-1673.
190. Brown DL. Pelvic ultrasound in the postabortion and postpartum patient.
Ultrasound Q. 2005;21(1):27-37.
191. Wachsberg RH, Kurtz AB. Gas within the endometrial cavity at postpartum
US: a normal inding ater spontaneous vaginal delivery. Radiology.
1992;183(2):431-433.
192. Van den Bosch T, Van Schoubroeck D, Timmerman D. Maximum peak
systolic velocity and management of highly vascularized retained products
of conception. J Ultrasound Med. 2015;34(9):1577-1582.
193. Kim SJ. Placental site trophoblastic tumour. Best Pract Res Clin Obstet
Gynaecol. 2003;17(6):969-984.
194. Zhou Y, Lu H, Yu C, et al. Sonographic characteristics of placental
site trophoblastic tumor. Ultrasound Obstet Gynecol. 2013;41(6):
679-684.
195. Huang MW, Muradali D, hurston WA, et al. Uterine arteriovenous malformations:
gray-scale and Doppler US features with MR imaging correlation.
Radiology. 1998;206(1):115-123.
196. O’Brien P, Neyastani A, Buckley AR, et al. Uterine arteriovenous malformations:
from diagnosis to treatment. J Ultrasound Med. 2006;25(11):
1387-1392.
197. Timmerman D, Wauters J, Van Calenbergh S, et al. Color Doppler
imaging is a valuable tool for the diagnosis and management of uterine
vascular malformations. Ultrasound Obstet Gynecol. 2003;21(6):
570-577.
198. Mungen E. Vascular abnormalities of the uterus: have we recently overdiagnosed
them? Ultrasound Obstet Gynecol. 2003;21(6):529-531.